Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data

Background: Neuraminidase inhibitors (NIs) are stockpiled and recommended by public health agencies for treating and preventing seasonal and pandemic influenza. They are used clinically worldwide. Objectives: To (1) describe the potential benefits and harms of NIs for influenza in all age groups by...

詳細記述

保存先:
書誌詳細
主要な著者: Carl J Heneghan, Igho Onakpoya, Mark A Jones, Peter Doshi, Chris B Del Mar, Rokuro Hama, Matthew J Thompson, Elizabeth A Spencer, Kamal R Mahtani, David Nunan, Jeremy Howick, Tom Jefferson
フォーマット: Artigo
言語:Inglês
出版事項: NIHR Journals Library 2016-05-01
シリーズ:Health Technology Assessment
主題:
neuraminidase inhibitors
influenza
systematic review
meta-analysis
regulatory data
mortality data
オンライン･アクセス:https://doi.org/10.3310/hta20420
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料